Rocket Pharmaceuticals In...

NASDAQ: RCKT · Real-Time Price · USD
3.04
0.01 (0.33%)
At close: Aug 15, 2025, 3:59 PM
3.02
-0.68%
After-hours: Aug 15, 2025, 07:30 PM EDT

Rocket Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-258.75M -245.59M -221.86M -169.07M
Depreciation & Amortization
9.38M 7.1M 6.27M 5.37M
Stock-Based Compensation
43.92M 39.41M 31.01M 29.24M
Other Working Capital
1.92M 13.46M -3.6M 1.44M
Other Non-Cash Items
-6.19M -9.28M 370K 13.53M
Deferred Income Tax
n/a n/a n/a 3.15M
Change in Working Capital
1.92M 13.46M 6.08M -3.39M
Operating Cash Flow
-209.72M -194.92M -178.14M -121.16M
Capital Expenditures
-5.86M -16.47M -8.62M -7.71M
Cash Acquisitions
n/a n/a 42.73M 95K
Purchase of Investments
-245.89M -390.92M -376.33M -245.88M
Sales Maturities Of Investments
383.45M 309.33M 272.89M 272.44M
Other Investing Acitivies
n/a n/a n/a -95K
Investing Cash Flow
131.71M -98.07M -69.33M 18.85M
Debt Repayment
95K 139K 172K 201K
Common Stock Repurchased
n/a n/a -47K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-95K -132K -172K -201K
Financial Cash Flow
185.74M 208.4M 155.29M 37.68M
Net Cash Flow
107.72M -84.58M -92.18M -64.63M
Free Cash Flow
-215.59M -211.39M -186.76M -128.88M